Open karafecho opened 1 year ago
@cartmanbeck - did we resolve the licensing issues with DrugBank or shall we keep this ticket open?
My understanding is that preliminary approval has been obtained, but NCATS is waiting on "official" approval.
In early 2023, MolePro and NCATS had submitted a "Terms of Service" document to DrugBank's CEO Michael Wilson for review and approval as a condition for gaining access to their drug-gene relationships. Subsequent and repeated entreaties to the CEO for any opinions have gone unanswered.
@sierra-moxon We need to keep this ticket open.
The licensing information that Tyler added to the DrugBank wiki page can be found here: https://github.com/NCATSTranslator/Translator-All/wiki/DrugBank. @cartmanbeck : Any updates?
This issue arose during a TAQA call. Specifically, Vlado noted that the next deployment of MolePro will not include drug-gene relationships due to licensing issues with DrugBank. Vlado has not received any response from DrugBank when he's reached out. Note that DrugBank provides roughly 25% of all drug-gene relationships in Translator, so the loss of the data will have a notable impact. A decision was therefore made for NCATS to discuss the issue internally to determine if it makes sense to reach out to the AMA, as was done with SNOMED. Creating a ticket here to circle back to previous discussions. Also see #63.